top of page
The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Georgia in 2022.
Economic
Output
$22.1B
Direct Jobs Supported by the Industry
12,750
Total Jobs Supported
76,021
State Total Vendor Relationships
1,462
State Total Vendor Spending
$1,364,544,064
Clinical
Trials
1,024
Investments at Clinical Trial Sites
$385.2M
Clinical Trial Participants
23,479
Total Economic Impact of Clinical Trial Sites
$1.11B
bottom of page